Viewing Study NCT03729505


Ignite Creation Date: 2025-12-25 @ 3:20 AM
Ignite Modification Date: 2026-02-28 @ 11:21 AM
Study NCT ID: NCT03729505
Status: COMPLETED
Last Update Posted: 2018-11-02
First Post: 2018-11-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Impact of Pyloric Injection of Magnesium Sulfate and Lidocaine Mixture on Outcome After Sleeve Gastrectomy
Sponsor:
Organization:

Raw JSON

{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D009767', 'term': 'Obesity, Morbid'}], 'ancestors': [{'id': 'D009765', 'term': 'Obesity'}, {'id': 'D050177', 'term': 'Overweight'}, {'id': 'D044343', 'term': 'Overnutrition'}, {'id': 'D009748', 'term': 'Nutrition Disorders'}, {'id': 'D009750', 'term': 'Nutritional and Metabolic Diseases'}, {'id': 'D001835', 'term': 'Body Weight'}, {'id': 'D012816', 'term': 'Signs and Symptoms'}, {'id': 'D013568', 'term': 'Pathological Conditions, Signs and Symptoms'}]}}, 'protocolSection': {'designModule': {'phases': ['NA'], 'studyType': 'INTERVENTIONAL', 'designInfo': {'allocation': 'RANDOMIZED', 'maskingInfo': {'masking': 'TRIPLE', 'whoMasked': ['PARTICIPANT', 'CARE_PROVIDER', 'OUTCOMES_ASSESSOR']}, 'primaryPurpose': 'TREATMENT', 'interventionModel': 'PARALLEL'}, 'enrollmentInfo': {'type': 'ACTUAL', 'count': 70}}, 'statusModule': {'overallStatus': 'COMPLETED', 'startDateStruct': {'date': '2017-07-01', 'type': 'ACTUAL'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2018-11', 'completionDateStruct': {'date': '2018-08-30', 'type': 'ACTUAL'}, 'lastUpdateSubmitDate': '2018-11-01', 'studyFirstSubmitDate': '2018-11-01', 'studyFirstSubmitQcDate': '2018-11-01', 'lastUpdatePostDateStruct': {'date': '2018-11-02', 'type': 'ACTUAL'}, 'studyFirstPostDateStruct': {'date': '2018-11-02', 'type': 'ACTUAL'}, 'primaryCompletionDateStruct': {'date': '2018-07-30', 'type': 'ACTUAL'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'Postoperative nausea and vomiting', 'timeFrame': 'first 24 hours after surgery', 'description': 'incidence of postoperative nausea and vomiting as measured by special impact scale'}]}, 'oversightModule': {'oversightHasDmc': False, 'isFdaRegulatedDrug': False, 'isFdaRegulatedDevice': False}, 'conditionsModule': {'conditions': ['Morbid Obesity']}, 'descriptionModule': {'briefSummary': 'Postoperative nausea and vomiting is a common adverse effect after sleeve gastrectomy, mostly due to increased intragastric pressure. The present trial aimed to assess the effect of pyloric injection of mixture of magnesium sulfate and lidocaine on postoperative gastric intraluminal pressure and incidence of nausea and vomiting.'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT', 'OLDER_ADULT'], 'maximumAge': '65 Years', 'minimumAge': '18 Years', 'healthyVolunteers': False, 'eligibilityCriteria': 'Inclusion Criteria:\n\n* Patients that aged between18 and 65 years.\n* American Society of Anesthesiologists (ASA) class I - III.\n* Morbidly-obese patients who failed to achieve and maintain a clinically significant weight loss through supervised non-surgical methods for at least 6 months.\n* Surgery was conducted as the first line of treatment in case of patients with BMI ≥ 50 kg/m2 (super obese).\n\nExclusion Criteria:\n\n* Obesity secondary to endocrine disorders.\n* History of any previous bariatric procedure.\n* Impaired intellectual capacity or major psyciatric disorder.\n* Sweet eaters who would not adopt a change of postoperative eating habits.\n* Lack of willingness and motivation to embrace postoperative lifestyle changes.\n* Substance abuse.\n* Pregnancy or expected pregnancy in the following 12 to 18 months.\n* Severe gastroesophageal reflux disease'}, 'identificationModule': {'nctId': 'NCT03729505', 'briefTitle': 'Impact of Pyloric Injection of Magnesium Sulfate and Lidocaine Mixture on Outcome After Sleeve Gastrectomy', 'organization': {'class': 'OTHER', 'fullName': 'Mansoura University'}, 'officialTitle': 'Impact of Pyloric Injection With Magnesium Sulphate and Lidocaine Mixture on Early Postoperative Outcome After Laparoscopic Sleeve Gastrectomy', 'orgStudyIdInfo': {'id': 'mansoura66'}}, 'armsInterventionsModule': {'armGroups': [{'type': 'ACTIVE_COMPARATOR', 'label': 'Pyloric injection of magnesium sulfate and lidocaine mixture', 'description': 'After sleeve gastrectomy, the pylorus is injected with a mixture of magnesium sulfate and lidocaine', 'interventionNames': ['Procedure: Pyloric injection of magnesium sulfate and lidocaine mixture']}, {'type': 'ACTIVE_COMPARATOR', 'label': 'Pyloric injection of saline', 'description': 'After sleeve gastrectomy, the pylorus is injected with normal saline', 'interventionNames': ['Procedure: Pyloric injection of saline']}], 'interventions': [{'name': 'Pyloric injection of magnesium sulfate and lidocaine mixture', 'type': 'PROCEDURE', 'description': '100 mg / 2 ml of magnesium sulphate (Magnesium Sulfate®) is mixed with 5 ml of 2% lidocaine and injected in the pylorus', 'armGroupLabels': ['Pyloric injection of magnesium sulfate and lidocaine mixture']}, {'name': 'Pyloric injection of saline', 'type': 'PROCEDURE', 'description': '5 ml of normal saline is injected in the pylorus', 'armGroupLabels': ['Pyloric injection of saline']}]}, 'contactsLocationsModule': {'locations': [{'zip': '35516', 'city': 'Al Mansurah', 'state': 'Dakahlia Governorate', 'country': 'Egypt', 'facility': 'Mansoura university hospital', 'geoPoint': {'lat': 31.03637, 'lon': 31.38069}}], 'overallOfficials': [{'name': 'Sameh H Emile', 'role': 'PRINCIPAL_INVESTIGATOR', 'affiliation': 'Mansoura University'}]}, 'ipdSharingStatementModule': {'ipdSharing': 'UNDECIDED'}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Mansoura University', 'class': 'OTHER'}, 'responsibleParty': {'type': 'PRINCIPAL_INVESTIGATOR', 'investigatorTitle': 'Lecturer of general surgery', 'investigatorFullName': 'Sameh Emile', 'investigatorAffiliation': 'Mansoura University'}}}}